# Cancer Epidemiology and Prevention Program

> **NIH NIH P30** · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2022 · $40,109

## Abstract

Abstract: Cancer Epidemiology and Prevention (CEP)
The overarching goal of the Cancer Epidemiology and Prevention (CEP) Program is to reduce cancer burden
and mortality in our catchment area and beyond through three interactive themes on the continuum from
cancer initiations to cancer prevention and early detection. Theme 1 is Discovery of Risk and Causative
Factors for Cancer Development and Progression with a specific aim to discover and characterize novel
modifiable and unmodifiable risk and causal factors for cancer development. Theme 2 is Cancer Prevention
with a specific aim to discover and evaluate novel anti-cancer natural compounds and vaccines for reduction of
cancer incidence. Theme 3 is Cancer Screening and Early Detection with a specific aim to develop and
validate novel biomarkers and modern imaging technologies for early diagnosis of cancer, for improvement of
cancer outcomes and reduction of cancer death. These themes reflect major working groups and initiatives
that coalesce program members with other cancer center investigators, through inter-programmatic
collaborations to achieve these specific aims.
Under the leadership of James Herman, MD (co-leader) and Jian-Min Yuan, MD, PhD (co-leader), the CEP
has 26 members representing 11 departments in 2 schools of the University of Pittsburgh. These Program
members have been awarded $5.4M (annual total direct) research grant funding, of which $3.6M is from the
NCI and $1.8M from other sources. All CEP members are engaged in cancer-relevant research focusing on
the discovery of novel risk/causative factors for the development of cancer, the efficacy of primary cancer
prevention strategies and effectiveness of cancer screening and early detection methods. CEP members
collaborate with and compliment the efforts of the BCC program, which focuses on implementation of risk
behavioral change programs such as smoking cessation and weight control and reduction. Between 2015 and
August 2019, CEP members published 639 cancer-relevant papers that resulted from 10% intra-programmatic,
27% inter-programmatic, and 81% inter-institutional collaborations and included high-impact publications in
Science, Nature, JAMA, Lancet, JNCI, and JCO. The program members bring their scientific vigor and
population-based research expertise to UPMC Hillman Cancer Center (HCC) and provide unique education
and training experience to the next generation of scientists to conduct cutting-edge translational research on
cancer etiology and prevention. With the outstanding support of HCC, this highly effective CEP has
successfully created synergy among the Program members with members of HCC other programs as well as
other cancer centers, which have resulted in many team science projects that advance the program’s research
agenda. Guided by the HCC strategic plan, the CEP members will develop and build large initiatives and
implement research projects that have significant impact on cancer burden in the HCC catchment area.

## Key facts

- **NIH application ID:** 10474529
- **Project number:** 5P30CA047904-34
- **Recipient organization:** UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- **Principal Investigator:** JAMES G. HERMAN
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $40,109
- **Award type:** 5
- **Project period:** 1997-09-10 → 2025-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10474529

## Citation

> US National Institutes of Health, RePORTER application 10474529, Cancer Epidemiology and Prevention Program (5P30CA047904-34). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10474529. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*